- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06586645
Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth
July 17, 2026 updated by: Florida International University
This project is designed to test a brief therapy to reduce suicidal ideation among a diverse sample of youths ages 12 to 17 who experience anxiety or depression.
The goal of the study is to conduct a clinical trial testing whether this therapy reduces suicidal ideation and related beliefs that one is a burden on others.
This project will contribute to the field by potentially showing evidence supportive of a brief strategy to reduce suicidal ideation in a way that can be readily understood and used by mental health providers in the community.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This project tests the ability of a brief therapy module to engage youth perceived burdensomeness (PB) in a rigorous randomized controlled trial (RCT) of the intervention, the "Give to Others (GO)" module.
The investigators will target PB among 60 ethnically/racially diverse clinic-referred youths (ages 12-17) who experience subacute suicide ideation SI (i.e., positive suicide risk screen; stable safety status).
Youths will be recruited from the clinical and community settings and will be randomized to one of the following 2 arms: an assessment and suicide risk management condition (Safety Planning control arm); and a Safety Planning plus GO module condition.
The investigators hypothesize that youths receiving the GO module will have lower levels of PB at post-treatment compared with youths who receive the control arm.
The investigators also hypothesize that youths receiving the GO module will have lower levels of PB at post-treatment compared to pre-treatment levels.
Study Type
Interventional
Enrollment (Actual)
61
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Miami, Florida, United States, 33199
- FIU Center for Children and Families
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria
Adolescents must:
- be between ages 12 and 17 years
- score at or above 4 on the Interpersonal Needs Questionnaire- Burdensomeness Scale
- have a positive screen for suicide risk (i.e., endorsement of suicidal ideation via self-report or parent-report).
Exclusion Criteria
For adolescents to be excluded, they must:
- have cognitive impairment or developmental delay which does not allow for the completion of basic study procedures (i.e., reading and filling out questionnaires; talking to a clinician)
- show imminent risk or a history of hurting themselves or others requiring intensive and restrictive services
- be involved currently in a psychosocial treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Safety Planning and "Give to Others" Module
A standard suicide risk assessment and management protocol followed by the "Give to Others" Module which is a brief cognitive behavioral intervention.
|
Safety planning is a standard suicide risk assessment and management protocol.
This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction.
The "Give to Others" Module is a brief cognitive behavioral intervention targeting youth burden-related beliefs.
It consists of one primary session and brief phone follow-up.
|
|
Active Comparator: Safety Planning
A standard suicide risk assessment and management protocol.
|
Safety planning is a standard suicide risk assessment and management protocol.
This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Self-report
Time Frame: post-intervention (within one week of completing the assigned intervention)
|
5-item youth self-ratings on perceived burdensomeness over the past week.
Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35.
Higher scores indicate higher levels of perceived burdensomeness (worse outcome).
|
post-intervention (within one week of completing the assigned intervention)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Parent report
Time Frame: post-intervention (within one week of completing the assigned intervention)
|
5-item parent ratings on youth perceived burdensomeness over the past week.
Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35.
Higher scores indicate higher levels of perceived burdensomeness (worse outcome).
|
post-intervention (within one week of completing the assigned intervention)
|
|
Sentence Completion Task- Liability Index
Time Frame: post-intervention (within one week of completing the assigned intervention)
|
28-item youth completed task assessing burden-related interpretation bias.
Participants read 28 sentences indicative of posing a liability on others and select negatively- or positively-valenced words to complete each sentence.
Each item is scored 0 or 1, yielding a total score between 0 and 28.
Higher scores indicate higher levels of burden interpretation bias (worse outcome).
|
post-intervention (within one week of completing the assigned intervention)
|
|
Sentence Completion Task- Social Contribution Index
Time Frame: post-intervention (within one week of completing the assigned intervention)
|
14-item youth completed task assessing contribution-related interpretation bias.
Participants read 14 sentences indicative of contributing to others and select negatively- or positively-valenced words to complete each sentence.
Each item is scored 0 or 1, yielding a total score between 0 and 14.
Higher scores indicate higher levels of contribution interpretation bias (better outcome).
|
post-intervention (within one week of completing the assigned intervention)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Victor Buitron, PhD, Florida International University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 11, 2025
Primary Completion (Actual)
December 11, 2025
Study Completion (Actual)
December 11, 2025
Study Registration Dates
First Submitted
September 4, 2024
First Submitted That Met QC Criteria
September 4, 2024
First Posted (Actual)
September 19, 2024
Study Record Updates
Last Update Posted (Actual)
July 20, 2026
Last Update Submitted That Met QC Criteria
July 17, 2026
Last Verified
July 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-24-0374
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.